Event Details
Returning for a fourth year in 2026, the RNA Vaccines and Therapeutics Conference will focus on the most recent developments in the rapidly evolving science of encoded RNA medicines.
Hosted by CPI, Imperial College London, and The BioIndustry Association (BIA), this two-day event will bring together a diverse range of experts from academia, biotech, pharma, and governmental and non-governmental agencies with a mix of invited and abstract-selected speakers together with poster sessions.
To find more information and continue to the conference page please click on the register button.
Agenda day 1 - Tuesday 15 September
9:15 — 9:30 — Welcome address: Robin Shattock, Professor at Imperial College London.
9:30 ‑10:15 — Keynote: The past, present and future of the nucleoside-modified mRNA technology — Norbert Pardi, Associate Professor at University of Pennsylvania Perelman School of Medicine.
10:15 — 11:05 Session 1 — RNA design and optimisation.
11:05 — 11:35 — Networking break.
11:35 — 12:40 — Session 2 — Formulation design and development.
12:40 — 13:55 — Lunch and networking.
13:55 — 14:55 — Panel discussion.
14:55 — 15:30 — Poster flash session.
15:30 — 16:00 — Networking break.
16:00 — 17:45 — Session 3 — RNA process modelling and manufacture (AI and digitisation).
17:45 — 19:00 — Drinks reception.
Agenda day 2 - ~Wednesday 16 September
9:15 — 9:20 — Welcome
9:20 — 10:05 — Keynote: Immunological mechanisms of mRNA vaccines, Karin Lore, Professor at Center for Molecular Medicine, Karolinska Institutet.
10:05 — 11:05 — Session 4 — RNA and formulation analytics.
10:50 — 11:20 — Networking break.
11:20 — 11:45 — Quick fire pitches.
11:45 — 13:00 — Session 5 — Therapeutics – preclinical and clinical evaluation.
13:00 — 14:00 — Lunch and networking.
14:00 — 14:55 — Session 6 — Vaccines: preclinical and clinical evaluation.
14:55 — 15:25 — Networking break.
15:25 ‑16:10 — Keynote: William Schief, Vice-President Protein Design, Moderna.
16:10 — 16:30 — Poster prizes.
16:30 — 16:40 — Conference wrap-up.
16:40 Conference close.
Sponsorship Opportunities
Download the official Sponsorship Brochure for the RNA Vaccines & Therapeutics Conference – London 2026 to explore high-impact branding and engagement opportunities.
With exclusive headline, poster, drinks, lunch and associate packages available, this is your opportunity to position your organisation at the heart of next-generation RNA innovation.
Abstract submissions
We are pleased to invite abstract submissions for the conference.
We are particularly keen to receive abstracts that showcase new scientific data, clear results, and meaningful developments. Submissions that are more descriptive in nature or do not include supporting evidence are less likely to be selected.
Please note that acceptance of an abstract does not include a conference ticket, so presenters will need to register separately to attend.
By submitting your abstract, you agree to it being published online and included in post-event materials.
The deadline for abstract submisson is 7 July 2026 at 5pm. Applicants will be advised on the outcome of their abstract application by email by 31 July 2026.
